Skip to main content
AZTAAzenta, Inc.Sell4.6·$25.84-1.34%
Open full analysis

Azenta, Inc. (AZTA) Stock Analysis

Recovery setup

SellVALUE-TRAP 2/5Moderate Confidence

Healthcare · Medical Instruments & Supplies

Sell if holding. Engine safety override at $25.84: Quality below floor (3.4 < 4.0) triggers a hard block regardless of the otherwise-positive setup — overall score 4.6/10. Specifically: High short interest: 21%; Below-average business quality; Below long-term trend.

Azenta, Inc. provides biological and chemical compound sample exploration and management solutions for the life sciences industry in the United States, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. It operates through Sample Management... Read more

$25.84+2.6% A.UpsideScore 4.6/10#27 of 32 Medical Instruments & Supplies
QualityF-score6 / 9FCF yield8.51%
Stop $24.03Target $26.51(resistance)A.R:R -0.8:1
Analyst target$26.20+1.4%5 analysts
$26.51our TP
$25.84price
$26.20mean
$20
$33

Sell if holding. Engine safety override at $25.84: Quality below floor (3.4 < 4.0) triggers a hard block regardless of the otherwise-positive setup — overall score 4.6/10. Specifically: High short interest: 21%; Below-average business quality; Below long-term trend. Chart setup: Death cross but MACD improving, RSI 73. Score 4.6/10, moderate confidence.

Passes 7/9 gates (positive momentum, clean insider activity, no SEC red flags, news events none recent, earnings proximity 31d clear, semi cycle peak clear, materials cycle peak clear). Fails on favorable risk/reward ratio. Suitability: aggressive.

TrendMatrix Research · upcoming catalyst calendar

Upcoming dated catalysts

Tue, Aug 4, 202631d to earnings· next earnings call

Thesis

Rewards
No bull case signals
Risks
Target reached (-11.8% upside)
Quality below floor (3.4 < 4.0)
Value-trap signals (2/5): Margin compression (op margin -50.8%), Material insider selling (6 sells, 0.21% of cap)

Key Metrics

P/E (TTM)
P/E (Fwd)42.1
Mkt Cap$1.2B
EV/EBITDA23.6
Profit Mgn-29.1%
ROE-6.8%
Rev Growth1.0%
Beta1.37
DividendNone
Rating analysts13

Quality Signals

Piotroski F6/9

Options Flow

P/C1.12bearish
IV89%elevated

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.

Show full disclosure ▾

About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.

Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.

Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.

No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.

No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.

Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.

Methodology · Editorial policy & full disclaimer

Rating Breakdown

4 floor-breakers

Technicals below the gate floor. Component breakdown shows what dragged the score down.static

Bollinger
0.9
Support Resistance
2.3
52w Position
2.4

No near-term catalyst priced in. Thesis progression will come from fundamentals grinding, not event reaction.static

Surprise Avg
0.0
Earnings History
1.1
Erm
5.0
Earnings Timing
5.0
Earnings concerns: 1B/2M

Ranks in the bottom of its industry peers on the composite signal. Better names in the same sector exist.static

Growth Rank
1.3
Quality Rank
1.4
Value Rank
6.3

Unprofitable operations — net margin -29.1%. Quality floor flags this regardless of sector context.static

Roe
0.0
Roa
0.0
Operating Margin
0.0
Net Margin
0.0
Moat
3.9
Gross Margin
4.9
Fcf Quality
6.0
Piotroski F
6.7
Current Ratio
9.5
FCF-positive but moderate margins (FCF margin 17%, FCF yield 8.5%)No competitive moat
GatesA.R:R -0.8=NEGATIVEDeath cross (50MA < 200MA)Momentum 5.9>=5.5Insider activity: OKNo SEC red flagsNEWS EVENTS NONE RECENTEARNINGS PROXIMITY 31d clearSEMI CYCLE PEAK CLEARMATERIALS CYCLE PEAK CLEARRecoverySuitability: Aggressive
RSI
73 · Overbought
20D MA 50D MA 200D MADEATH CROSSSupport $21.77Resistance $27.05

Price Targets

$24
$27
A.Upside+2.6%
A.R:R-0.8:1

Position Sizing

ConvictionNone
Suggested %0.5%
Max %1%
RegimeSteady

Risk Alerts

! Target reached (-11.8% upside)
! Quality below floor (3.4 < 4.0)
! Value-trap signals (2/5): Margin compression (op margin -50.8%), Material insider selling (6 sells, 0.21% of cap)

Earnings

B
M
M
M
1/4 beats
Next Earnings2026-08-04 (31d)

Verdict History

reverse chrono — latest first
Loading history...
Verdicts are recorded on every nightly pipeline run. Rows capture transitions (verdict flips, score deltas ≥0.3, entry/TP/SL changes). Rows with a ▶ can be expanded to see the change reason. Aggregate cohort performance is tracked in the recommendation ledger.
Frequently Asked Questions
Is AZTA stock a buy right now?

Sell if holding. Engine safety override at $25.84: Quality below floor (3.4 < 4.0) triggers a hard block regardless of the otherwise-positive setup — overall score 4.6/10. Specifically: High short interest: 21%; Below-average business quality; Below long-term trend. Chart setup: Death cross but MACD improving, RSI 73. Prior stop was $24.03. Score 4.6/10, moderate confidence.

What is the AZTA stock price target?

Take-profit target: $26.51 (+2.6% upside). Prior stop was $24.03. Stop-loss: $24.03.

What are the risks of investing in AZTA?

Target reached (-11.8% upside); Quality below floor (3.4 < 4.0); Value-trap signals (2/5): Margin compression (op margin -50.8%), Material insider selling (6 sells, 0.21% of cap).

Is AZTA overvalued or undervalued?

Azenta, Inc. trades at a P/E of N/A (forward 42.1). TrendMatrix value score: 4.9/10. Verdict: Sell.

What do analysts say about AZTA?

13 analysts cover AZTA with a consensus score of 3.9/5. Average price target: $26.

What does Azenta, Inc. do?Azenta, Inc. provides biological and chemical compound sample exploration and management solutions for the life...

Azenta, Inc. provides biological and chemical compound sample exploration and management solutions for the life sciences industry in the United States, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. It operates through Sample Management Solutions and Multiomics segments. The Sample Management Solutions segment provides sample management products and services, including automated stores, cryogenic systems, automated sample tubes, consumables and instruments, and controlled rate thawing devices, as well as sample repository services. This segment also offers consultation services to clients throughout their experimental design and implementation processes. The Multiomics segment provides genomic and other sample analysis services comprising gene sequencing, gene synthesis, and related services. The company has a strategic partnership with Frontier Space Ltd to conduct scientific experiments in space. The company was formerly known as Brooks Automation, Inc. and changed its name to Azenta, Inc. in December 2021. Azenta, Inc. was founded in 1978 and is headquartered in Burlington, Massachusetts.

Related stocks: STAA (STAAR Surgical Company) · NVST (Envista Holdings Corporation) · TFX (Teleflex Incorporated) · LMAT (LeMaitre Vascular, Inc.) · MMSI (Merit Medical Systems, Inc.)
Home Stocks AZTA

Latest news

No recent news